Salud financiera de hoja de balance de LivaNova
Salud financiera controles de criterios 3/6
LivaNova tiene un patrimonio de accionistas total de $1.3B y una deuda total de $586.7M, lo que sitúa su ratio deuda-patrimonio en 45.9%. Sus activos y pasivos totales son $2.4B y $1.2B respectivamente. El BAIT de LivaNova es de $66.4M, por lo que su ratio de cobertura de intereses es de 1.9. Tiene efectivo e inversiones a corto plazo que ascienden a $266.5M.
Información clave
45.9%
Ratio deuda-patrimonio
US$586.65m
Deuda
| Ratio de cobertura de intereses | 1.9x |
| Efectivo | US$266.50m |
| Patrimonio | US$1.28b |
| Total pasivo | US$1.15b |
| Activos totales | US$2.43b |
Actualizaciones recientes sobre salud financiera
Recent updates
These Return Metrics Don't Make LivaNova (NASDAQ:LIVN) Look Too Strong
Apr 08
Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?
Feb 05A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)
Jan 15LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry
Dec 25LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company
Nov 29We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 08At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Oct 16Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?
Sep 25Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Jul 26Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?
Jul 03An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued
Jun 09Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital
Apr 13What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?
Mar 13Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Feb 15Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up
Nov 25Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Oct 29LivaNova Loses Profit Momentum On Higher R&D Expense
Oct 13LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate
Oct 11FDA labels recall of blood bypass pump systems by LivaNova as most serious
Sep 30Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes
Aug 09LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
Aug 03Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Jul 19A Look At The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Jun 27LivaNova Matures Into Profitability, Still Waiting On DTD
May 10Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Apr 05LivaNova Continues To Be A Spring-Loaded Opportunity In Neuromodulation
Feb 11Is LivaNova PLC (NASDAQ:LIVN) Trading At A 35% Discount?
Jan 30At US$87.75, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Dec 29Does LivaNova (NASDAQ:LIVN) Have A Healthy Balance Sheet?
Nov 29Milan Court Decision Does Not Change LivaNova Bullish Story
Nov 16Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($988.2M) de LIVN superan a sus pasivos a corto plazo ($335.0M).
Pasivo a largo plazo: Los activos a corto plazo de LIVN ($988.2M) superan a sus pasivos a largo plazo ($817.0M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (25.1%) de LIVN se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de LIVN ha crecido de 11.3% a 45.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de LIVN no está bien cubierta por el flujo de caja operativo (12.8%).
Cobertura de intereses: Los pagos de intereses de la deuda de LIVN no están bien cubiertos por el BAIT (1.9x cobertura).